DANIEL OATES: Open Payments
NPI 1326596354 · BAY MINETTE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$990 in 59 payments from 11 companies in 2025. Trend: 2023 $465 · 2024 $658 · 2025 $990
Food & beverage: $990
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 24 | $282 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $216 |
| AstraZeneca Pharmaceuticals LP | 10 | $204 |
| Novo Nordisk Inc | 6 | $107 |
| ABBVIE INC. | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
Products named: CAPLYTA, OTEZLA, AIRSUPRA, Rybelsus, EVENITY, BREZTRI, VRAYLAR, Ozempic.
Industry payments across AL — which companies pay providers there.
